These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16999848)

  • 21. Fondaparinux versus enoxaparin for the prevention of venous thromboembolism.
    Doggrell SA
    Expert Opin Pharmacother; 2002 Apr; 3(4):455-7. PubMed ID: 11934350
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing, preventing, and treating venous thromboembolism: evidence-based approaches.
    Nutescu EA
    Am J Health Syst Pharm; 2007 Jun; 64(11 Suppl 7):S5-13. PubMed ID: 17519445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fondaparinux combined with intermittent pneumatic compression vs. intermittent pneumatic compression alone for prevention of venous thromboembolism after abdominal surgery: a randomized, double-blind comparison.
    Turpie AG; Bauer KA; Caprini JA; Comp PC; Gent M; Muntz JE;
    J Thromb Haemost; 2007 Sep; 5(9):1854-61. PubMed ID: 17723125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trials of new anticoagulants.
    Anderson J; O'Donnell M
    Vnitr Lek; 2006 Mar; 52 Suppl 1():123-6. PubMed ID: 16637460
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Fondaparinux for thrombosis prevention after orthopaedic surgery: a revolution?].
    Monreal M
    Med Clin (Barc); 2003 May; 120(20):775-6. PubMed ID: 12797930
    [No Abstract]   [Full Text] [Related]  

  • 26. Cost considerations surrounding current and future anticoagulant therapies.
    Fang MC; Minichiello T; Auerbach AD
    Cleve Clin J Med; 2005 Apr; 72 Suppl 1():S43-9. PubMed ID: 15853179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Guidelines for anticoagulation therapy for venous thromboembolism.
    Cundiff DK
    J Gen Intern Med; 2002 Jan; 17(1):85. PubMed ID: 11903782
    [No Abstract]   [Full Text] [Related]  

  • 28. The design of venous thromboembolism prophylaxis trials: fondaparinux is definitely more effective than enoxaparin in orthopaedic surgery.
    Turpie AG
    Int J Clin Pract; 2004 May; 58(5):483-93. PubMed ID: 15206506
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-molecular-weight heparins and heparinoids.
    Williamson OD; Street AM
    Med J Aust; 2003 Apr; 178(8):414; author reply 414-5. PubMed ID: 12776722
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylaxis and treatment of venous thromboembolism in patients with cancer.
    Ageno W; Squizzato A
    Intern Emerg Med; 2006; 1(4):260-2. PubMed ID: 17217144
    [No Abstract]   [Full Text] [Related]  

  • 31. New anticoagulants for treatment of venous thromboembolism.
    Weitz JI
    Circulation; 2004 Aug; 110(9 Suppl 1):I19-26. PubMed ID: 15339877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Management of acute coronary syndromes with fondaparinux.
    Wienbergen H; Zeymer U
    Vasc Health Risk Manag; 2007; 3(3):321-9. PubMed ID: 17703640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial management of deep venous thrombosis in the outpatient setting.
    Groce JB
    Am J Health Syst Pharm; 2008 May; 65(9):866-74. PubMed ID: 18436734
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of venous thromboembolism with fondaparinux.
    Scacewater R
    N Engl J Med; 2002 Mar; 346(12):940-2; author reply 940-2. PubMed ID: 11911135
    [No Abstract]   [Full Text] [Related]  

  • 35. Factor X inhibitors.
    Tan KT; Makin A; Lip GY
    Expert Opin Investig Drugs; 2003 May; 12(5):799-804. PubMed ID: 12720491
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fondaparinux in the management of recurrent venous thromboembolic events in a patient with active lung cancer.
    Ten Heuvel A; Schramel FM; Biesma DH
    Thromb Res; 2007; 120(4):635-7. PubMed ID: 17257658
    [No Abstract]   [Full Text] [Related]  

  • 37. Trousseau's syndrome in a patient with adenocarcinoma of unknown primary and therapy-resistant venous thrombosis treated with dabigatran and fondaparinux.
    Beyer-Westendorf J; Werth S; Folprecht G; Weiss N
    Br J Clin Pharmacol; 2011 Oct; 72(4):715-6. PubMed ID: 21392076
    [No Abstract]   [Full Text] [Related]  

  • 38. Fondaparinux, the first selective factor Xa inhibitor.
    Turpie AG; Eriksson BI; Lassen MR; Bauer KA
    Curr Opin Hematol; 2003 Sep; 10(5):327-32. PubMed ID: 12913785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Refractory venous thrombus propagation in the setting of therapeutic anticoagulation.
    Traeger ZT; Rizzo JR; Rashbaum I
    Am J Phys Med Rehabil; 2011 Oct; 90(10):873-4. PubMed ID: 21862910
    [No Abstract]   [Full Text] [Related]  

  • 40. Pentasaccharides in the prophylaxis and treatment of venous thromboembolism: a systematic review.
    Nijkeuter M; Huisman MV
    Curr Opin Pulm Med; 2004 Sep; 10(5):338-44. PubMed ID: 15316429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.